Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Mitsunaga, Makoto ^a   Nakajima, Takahito ^a   Sano, Kohei ^a   Kramer Marek, Gabriela ^a   Choyke, Peter L ^a   Kobayashi, Hisataka ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Bioluminescence imaging; Cell death; Epidermal growth factor receptor; Molecular targeting; Monoclonal antibody; Photoimmunotherapy; Theranostics

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PANITUMUMAB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; BREAST CANCER; CANCER CELL; CELL DEATH; CELL KILLING; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; FEMALE; FLUORESCENCE MICROSCOPY; HISTOPATHOLOGY; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; LIGHT EXPOSURE; LIGHT INTENSITY; MOUSE; NEAR INFRARED PHOTOIMMUNOTHERAPY; NONHUMAN; TUMOR VOLUME;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; COMBINED MODALITY THERAPY; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; IMMUNOCONJUGATES; IMMUNOTHERAPY; INDOLES; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; NECROSIS; PHOTOCHEMOTHERAPY; RADIATION-SENSITIZING AGENTS; RANDOM ALLOCATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84864542226     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-345     Document Type: Article

References (19)

1. Waldmann TA. Immunotherapy: past, present and future. Nat Med 2003, 9:269-277. 10.1038/nm0303-269, 12612576.
2. Pastan I, Hassan R, Fitzgerald DJ, Kreitman RJ. Immunotoxin therapy of cancer. Nat Rev Cancer 2006, 6:559-565. 10.1038/nrc1891, 16794638.
3. Mitsunaga M, Ogawa M, Kosaka N, Rosenblum LT, Choyke PL, Kobayashi H. Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat Med 2011, 17:1685-1691. 10.1038/nm.2554, 3233641, 22057348.
4. Mitsunaga M, Nakajima T, Sano K, Choyke PL, Kobayashi H. Near-infrared theranostic photoimmunotherapy (PIT): repeated exposure of light enhances the effect of immunoconjugate. Bioconjug Chem 2012, 23:604-609. 10.1021/bc200648m, 22369484.
5. Contag PR, Olomu IN, Stevenson DK, Contag CH. Bioluminescent indicators in living mammals. Nat Med 1998, 4:245-247. 10.1038/nm0298-245, 9461201.
6. Rehemtulla A, Stegman LD, Cardozo SJ, Gupta S, Hall DE, Contag CH, Ross BD. Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2000, 2:491-495. 10.1038/sj.neo.7900121, 1508085, 11228541.
7. Dothager RS, Flentie K, Moss B, Pan MH, Kesarwala A, Piwnica-Worms D. Advances in bioluminescence imaging of live animal models. Curr Opin Biotechnol 2009, 20:45-53. 10.1016/j.copbio.2009.01.007, 2680462, 19233638.
8. Lyakhov I, Zielinski R, Kuban M, Kramer-Marek G, Fisher R, Chertov O, Bindu L, Capala J. HER2- and EGFR-specific affiprobes: novel recombinant optical probes for cell imaging. ChemBioChem 2010, 11:345-350. 10.1002/cbic.200900532, 3092587, 20052708.
9. Leist M, Single B, Castoldi AF, Kuhnle S, Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 1997, 185:1481-1486. 10.1084/jem.185.8.1481, 2196283, 9126928.
10. Zamaraeva MV, Sabirov RZ, Maeno E, Ando-Akatsuka Y, Bessonova SV, Okada Y. Cells die with increased cytosolic ATP during apoptosis: a bioluminescence study with intracellular luciferase. Cell Death Differ 2005, 12:1390-1397. 10.1038/sj.cdd.4401661, 15905877.
11. McNeil PL, Steinhardt RA. Plasma membrane disruption: repair, prevention, adaptation. Annu Rev Cell Dev Biol 2003, 19:697-731. 10.1146/annurev.cellbio.19.111301.140101, 14570587.
12. Hoffman RM. The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat Rev Cancer 2005, 5:796-806. 10.1038/nrc1717, 16195751.
13. Hoffman RM, Yang M. Subcellular imaging in the live mouse. Nat Protoc 2006, 1:775-782. 10.1038/nprot.2006.109, 17406307.
14. Jiang P, Yamauchi K, Yang M, Tsuji K, Xu M, Maitra A, Bouvet M, Hoffman RM. Tumor cells genetically labeled with GFP in the nucleus and RFP in the cytoplasm for imaging cellular dynamics. Cell Cycle 2006, 5:1198-1201. 10.4161/cc.5.11.2795, 16760659.
15. Yamamoto N, Jiang P, Yang M, Xu M, Yamauchi K, Tsuchiya H, Tomita K, Wahl GM, Moossa AR, Hoffman RM. Cellular dynamics visualized in live cells in vitro and in vivo by differential dual-color nuclear-cytoplasmic fluorescent-protein expression. Cancer Res 2004, 64:4251-4256. 10.1158/0008-5472.CAN-04-0643, 15205338.
16. Kimura H, Lee C, Hayashi K, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Bouvet M, Hoffman RM. UV light killing efficacy of fluorescent protein-expressing cancer cells in vitro and in vivo. J Cell Biochem 2010, 110:1439-1446. 10.1002/jcb.22693, 20506255.
17. Tsai MH, Aki R, Amoh Y, Hoffman RM, Katsuoka K, Kimura H, Lee C, Chang CH. GFP-fluorescence-guided UVC irradiation inhibits melanoma growth and angiogenesis in nude mice. Anticancer Res 2010, 30:3291-3294.
18. Shimomura O. Discovery of green fluorescent protein (GFP) (Nobel Lecture). Angew Chem Int Ed Engl 2009, 48:5590-5602. 10.1002/anie.200902240, 19579247.
19. Hoffman RM. Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs 1999, 17:343-359. 10.1023/A:1006326203858, 10759402.